Causal Effects of Breast Cancer Risk Factors across Hormone Receptor Breast Cancer Subtypes: A Two-Sample Mendelian Randomization Study

Abstract

Background:

It is unclear if established breast cancer risk factors exert similar causal effects across hormone receptor breast cancer subtypes. We estimated and compared causal estimates of height, body mass index (BMI), type 2 diabetes, age at menarche, age at menopause, breast density, alcohol consumption, regular smoking, and physical activity across these subtypes.

Methods:

We used a two-sample Mendelian randomization approach and selected genetic instrumental variables from large-scale genome-wide association studies. Publicly available summary-level Breast Cancer Association Consortium data (n = 247,173; 133,384 cases, 113,789 controls) for the following subtypes were included: luminal A–like (45,253 cases), luminal B–/HER2-negative–like (6,350 cases), luminal B–like (6,427 cases), HER2-enriched (2,884 cases), and triple-negative (8,602 cases). We employed multiple Mendelian randomization methods to evaluate the strength of causal evidence for each risk factor–subtype association.

Results:

Collectively, our analyses indicated that increased height and decreased BMI are probable causal risk factors for all five subtypes. For the other risk factors, the strength of evidence for causal effects differed across subtypes. Heterogeneity in the magnitude of causal effect estimates for age at menopause and breast density was explained by null findings for triple-negative tumors. Regular smoking was the sole risk factor for which there was no evidence of a causal effect on any subtype.

Conclusions:

This study suggests that established breast cancer risk factors differ across hormone receptor subtypes.

Impact:

Our results are valuable for the development of primary prevention strategies, improvement of breast cancer risk stratification in the general population, and identification of novel breast cancer risk factors.

Funding

Cancer Research UK

10692

Ovarian Cancer Research Fund (OCRF)

Breast Cancer Research Foundation (BCRF)

Wellcome Trust (WT)

225790/Z/22/Z

Cancer Research UK

16565

Cancer Research UK

20861

Horizon 2020 Framework Programme (H2020)

633784

Seventh Framework Programme (FP7)

223175 (HEALTH-F2-2009-223175)

National Institutes of Health (NIH)

CA148112

NCI NIH HHS

U19 CA148112

Cancer Research UK (CRUK)

C5047/A15007

NCI NIH HHS

U19 CA148065

Genome Canada (GC)

GPH-129344

Wellcome Trust

100114

Cancer Research UK (CRUK)

C12292/A20861

The Dutch Ministry of Health, Welfare and Sport

Cancer Research UK

10710

Medical Research Council (MRC)

MC_UU_00040/01

Cancer Research UK

12014

Fondation du cancer du sein du Québec (FCSQ)

Medical Research Council (MRC)

MC_UU_00002/7

Cancer Research UK (CRUK)

C5047/A8384

Cancer Research UK

11174

Cancer Research UK (CRUK)

PPRPGM-Nov20\100002

U.S. Department of Defense (DOD)

W81XWH-10-1-0341

National Institutes of Health (NIH)

CA128978

Cancer Research UK (CRUK)

C8197/A16565

Cancer Research UK (CRUK)

C1287/A10710

Cancer Research UK (CRUK)

C1287/A10118

NCI NIH HHS

R01 CA128978

Horizon 2020 Framework Programme (H2020)

634935

NCI NIH HHS

U19 CA148537

Cancer Research UK (CRUK)

C12292/A11174

Susan G. Komen (SGK)

Cancer Research UK

15007

Cancer Research UK (CRUK)

C1287/A16563

Antonie van Leeuwenhoek Foundation

Canadian Institutes of Health Research (CIHR)

CRN-87521

Cancer Research UK

16563

National Institutes of Health (NIH)

X01HG007492

KWF Kankerbestrijding (DCS)

Cancer Research UK (CRUK)

C5047/A10692

Ministère de l'Économie, de la Science et de l'Innovation - Québec (MESI)

PSRSIIRI-701

Gray Foundation

Cancer Research UK

10118

Cancer Research UK (CRUK)

C1281/A12014

National Institutes of Health (NIH)

CA148065

Wellcome Trust

225790/Z/22/Z

Medical Research Council

MC_UU_00002/7

Medical Research Council

MC_UU_00040/01

National Institutes of Health

CA128978

National Institutes of Health

X01HG007492

Genome Canada

GPH-129344

Ministère de l'Économie, de la Science et de l'Innovation - Québec

PSRSIIRI-701

Fondation du cancer du sein du Québec

Seventh Framework Programme

223175 (HEALTH-F2-2009-223175)

Horizon 2020 Framework Programme

634935

Horizon 2020 Framework Programme

633784

National Institutes of Health

U19 CA148537

National Institutes of Health

CA148065

National Institutes of Health

CA148112

U.S. Department of Defense

W81XWH-10-1-0341

Canadian Institutes of Health Research

CRN-87521

Susan G. Komen

Breast Cancer Research Foundation

Ovarian Cancer Research Fund

KWF Kankerbestrijding

Cancer Research UK

PPRPGM-Nov20\100002

Cancer Research UK

C1287/A10118

Cancer Research UK

C1287/A16563

Cancer Research UK

C1287/A10710

Cancer Research UK

C12292/A20861

Cancer Research UK

C12292/A11174

Cancer Research UK

C1281/A12014

Cancer Research UK

C5047/A8384

Cancer Research UK

C5047/A15007

Cancer Research UK

C5047/A10692

Cancer Research UK

C8197/A16565